---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-056748"
form_type: "8-K"
ticker: null
cik: "0000786947"
company_name: "ACURA PHARMACEUTICALS, INC"
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T22:19:21.532855+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Acura's debt to related party grows to $10.3M; warns of possible shutdown without new financing by May-end

## Summary
- Received four $100,000 loans from Abuse Deterrent Pharma on March 30, April 3, April 20, May 5, 2026, bringing principal to $10,294,279.
- Accrued interest ~$1,090,000 as of May 5; interest rate 5.25% (7.5% on default).
- Without additional financing by end of May 2026, company will need to scale back operations, furlough employees, or seek bankruptcy.
- AD Pharma, which owns ~65% of Acura's common stock, is controlled by Mr. Schutte, who also owns ~13% directly.

## SEC filing metadata
- accession: 0001104659-26-056748
- form_type: 8-K
- cik: 0000786947
- company_name: ACURA PHARMACEUTICALS, INC
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/786947/000110465926056748/0001104659-26-056748-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/786947/000110465926056748/tm2613771d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-056748
- JSON: https://secwatch.observer/filing/0001104659-26-056748.json
- Plain text: https://secwatch.observer/filing/0001104659-26-056748.txt

## Source-grounded claims
- claim_id: 5bbe4eca4279586b3c2d8f4d905216cae3ccb86f
  claim: ACURA PHARMACEUTICALS, INC incurred loan of $100,000 with Abuse Deterrent Pharma, LLC at 5.25%.
  evidence_excerpt: On each of March 30, 2026, April 3, 2026, April 20, 2026 and May 5, 2026, we received loans of $100,000 from Abuse Deterrent Pharma, LLC (“AD Pharma”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/786947/000110465926056748/0001104659-26-056748-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.